Foye, William O., Lemke, Thomas L., Williams, David A.:Foye's principles of medicinal chemistry, s. 1286-. (6. painos)Lippincott Williams & Wilkins, 2008.ISBN9780781768795Teoksen verkkoversio.
Burger, Alfred:Burger's medicinal chemistry and drug discovery. 4, Autocoids, diagnostics, and drugs from new biology, s. 439.Hoboken, New Jersey:Wiley, 2003.51251820ISBN9780471370307Teoksen verkkoversio.
Blume-Peytavi U, Whiting DA, Trüeb RM:Hair growth and disorders, s. 369.Berlin:Springer Science & Business Media, 2008.ISBN9783540469117Teoksen verkkoversio.
Timothy J. Wilt, Roderick Macdonald, Karen Hagerty, Paul Schellhammer, James Tacklind, Mark R. Somerfield:5-α-Reductase inhibitors for prostate cancer chemoprevention: an updated Cochrane systematic review.BJU international,marraskuu 2010, 106. vsk, nro 10, s. 1444–1451.PubMed:20977593doi:10.1111/j.1464-410X.2010.09714.xISSN1464-410XArtikkelin verkkoversio.
Silvia Paba, Roberto Frau, Sean C. Godar, Paola Devoto, Francesco Marrosu, Marco Bortolato:Steroid 5α-reductase as a novel therapeutic target for schizophrenia and other neuropsychiatric disorders.Current Pharmaceutical Design,2011, 17. vsk, nro 2, s. 151–167.PubMed:21361868ISSN1873-4286Artikkelin verkkoversio.
Timothy J. Wilt, Roderick Macdonald, Karen Hagerty, Paul Schellhammer, James Tacklind, Mark R. Somerfield:5-α-Reductase inhibitors for prostate cancer chemoprevention: an updated Cochrane systematic review.BJU international,marraskuu 2010, 106. vsk, nro 10, s. 1444–1451.PubMed:20977593doi:10.1111/j.1464-410X.2010.09714.xISSN1464-410XArtikkelin verkkoversio.
Jason M. Hirshburg, Petra A. Kelsey, Chelsea A. Therrien, A. Carlo Gavino, Jason S. Reichenberg:Adverse Effects and Safety of 5-alpha Reductase Inhibitors (Finasteride, Dutasteride): A Systematic Review.The Journal of Clinical and Aesthetic Dermatology,heinäkuu 2016, 9. vsk, nro 7, s. 56–62.PubMed:27672412ISSN1941-2789Artikkelin verkkoversio.
Silvia Paba, Roberto Frau, Sean C. Godar, Paola Devoto, Francesco Marrosu, Marco Bortolato:Steroid 5α-reductase as a novel therapeutic target for schizophrenia and other neuropsychiatric disorders.Current Pharmaceutical Design,2011, 17. vsk, nro 2, s. 151–167.PubMed:21361868ISSN1873-4286Artikkelin verkkoversio.
Jason M. Hirshburg, Petra A. Kelsey, Chelsea A. Therrien, A. Carlo Gavino, Jason S. Reichenberg:Adverse Effects and Safety of 5-alpha Reductase Inhibitors (Finasteride, Dutasteride): A Systematic Review.The Journal of Clinical and Aesthetic Dermatology,heinäkuu 2016, 9. vsk, nro 7, s. 56–62.PubMed:27672412ISSN1941-2789Artikkelin verkkoversio.
Timothy J. Wilt, Roderick Macdonald, Karen Hagerty, Paul Schellhammer, James Tacklind, Mark R. Somerfield:5-α-Reductase inhibitors for prostate cancer chemoprevention: an updated Cochrane systematic review.BJU international,marraskuu 2010, 106. vsk, nro 10, s. 1444–1451.PubMed:20977593doi:10.1111/j.1464-410X.2010.09714.xISSN1464-410XArtikkelin verkkoversio.
Timothy J. Wilt, Roderick Macdonald, Karen Hagerty, Paul Schellhammer, James Tacklind, Mark R. Somerfield:5-α-Reductase inhibitors for prostate cancer chemoprevention: an updated Cochrane systematic review.BJU international,marraskuu 2010, 106. vsk, nro 10, s. 1444–1451.PubMed:20977593doi:10.1111/j.1464-410X.2010.09714.xISSN1464-410XArtikkelin verkkoversio.
Jason M. Hirshburg, Petra A. Kelsey, Chelsea A. Therrien, A. Carlo Gavino, Jason S. Reichenberg:Adverse Effects and Safety of 5-alpha Reductase Inhibitors (Finasteride, Dutasteride): A Systematic Review.The Journal of Clinical and Aesthetic Dermatology,heinäkuu 2016, 9. vsk, nro 7, s. 56–62.PubMed:27672412ISSN1941-2789Artikkelin verkkoversio.
Silvia Paba, Roberto Frau, Sean C. Godar, Paola Devoto, Francesco Marrosu, Marco Bortolato:Steroid 5α-reductase as a novel therapeutic target for schizophrenia and other neuropsychiatric disorders.Current Pharmaceutical Design,2011, 17. vsk, nro 2, s. 151–167.PubMed:21361868ISSN1873-4286Artikkelin verkkoversio.